Mapatumumab (HGS-ETR1)
Revision as of 19:55, 27 February 2020 by Warner-admin (talk | contribs) (Text replacement - "Category:Antibody medications" to "")
Mechanism of action
Monoclonal antibody directed against the tumour necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1)